Perfil
Neena Kadaba is currently a Director at Eyevensys SAS since 2020.
Prior to this, she worked as a Partner at Mission Bay Capital Management, Inc. from 2014 to 2015.
Dr. Kadaba completed her undergraduate and graduate degrees from Massachusetts Institute of Technology in 2003 and received her doctorate degree from California Institute of Technology in 2008.
Cargos activos de Neena Kadaba
| Empresas | Cargo | Inicio |
|---|---|---|
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Develops non-viral gene therapy process for the treatment of ocular illnesses | Director/Miembro de la Junta | 08/01/2020 |
Antiguos cargos conocidos de Neena Kadaba.
| Empresas | Cargo | Fin |
|---|---|---|
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital invests in companies located in the United States. The firm focuses on the biotechnology and life sciences sector. It participates in early stage capital transactions. Mission Bay Capital reorganized its operating segments on January 21,2020, by combining BioInnovation Management LLC and Mission Bay Capital Management Inc into a single segment called - Mission BioCapital. | Inversor de Capital Privado | 31/12/2015 |
Formación de Neena Kadaba.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital invests in companies located in the United States. The firm focuses on the biotechnology and life sciences sector. It participates in early stage capital transactions. Mission Bay Capital reorganized its operating segments on January 21,2020, by combining BioInnovation Management LLC and Mission Bay Capital Management Inc into a single segment called - Mission BioCapital. | Finance |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Develops non-viral gene therapy process for the treatment of ocular illnesses | Commercial Services |
- Bolsa de valores
- Insiders
- Neena Kadaba
















